IN192743B - - Google Patents

Info

Publication number
IN192743B
IN192743B IN58DE2002A IN192743B IN 192743 B IN192743 B IN 192743B IN 58DE2002 A IN58DE2002 A IN 58DE2002A IN 192743 B IN192743 B IN 192743B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Clifford S Labaw
Joseph Robert Flisak
Li Liu
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Priority to IN58DE2002 priority Critical patent/IN192743B/en
Publication of IN192743B publication Critical patent/IN192743B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
IN58DE2002 1997-02-14 2002-01-28 IN192743B (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN58DE2002 IN192743B (enExample) 1997-02-14 2002-01-28

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3819597P 1997-02-14 1997-02-14
IN360DE1998 IN187999B (enExample) 1997-02-14 1998-02-12
IN58DE2002 IN192743B (enExample) 1997-02-14 2002-01-28

Publications (1)

Publication Number Publication Date
IN192743B true IN192743B (enExample) 2004-05-15

Family

ID=21898583

Family Applications (2)

Application Number Title Priority Date Filing Date
IN360DE1998 IN187999B (enExample) 1997-02-14 1998-02-12
IN58DE2002 IN192743B (enExample) 1997-02-14 2002-01-28

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN360DE1998 IN187999B (enExample) 1997-02-14 1998-02-12

Country Status (41)

Country Link
US (1) US6172237B1 (enExample)
EP (1) EP0970073B1 (enExample)
JP (1) JP4537499B2 (enExample)
KR (1) KR100573638B1 (enExample)
CN (1) CN1085208C (enExample)
AP (1) AP1128A (enExample)
AR (1) AR011125A1 (enExample)
AT (1) ATE280765T1 (enExample)
AU (1) AU730383B2 (enExample)
BG (1) BG63804B1 (enExample)
BR (1) BR9808664A (enExample)
CA (1) CA2281708C (enExample)
CO (1) CO4950550A1 (enExample)
CY (1) CY2555B1 (enExample)
CZ (1) CZ296349B6 (enExample)
DE (1) DE69827240T2 (enExample)
DK (1) DK0970073T3 (enExample)
EA (1) EA001659B1 (enExample)
EG (1) EG23935A (enExample)
ES (1) ES2231963T3 (enExample)
HU (1) HU228781B1 (enExample)
ID (1) ID23181A (enExample)
IL (1) IL131309A (enExample)
IN (2) IN187999B (enExample)
MA (1) MA24470A1 (enExample)
MY (1) MY118704A (enExample)
NO (1) NO317194B1 (enExample)
NZ (1) NZ337180A (enExample)
OA (1) OA11146A (enExample)
PE (1) PE59299A1 (enExample)
PL (1) PL192838B1 (enExample)
PT (1) PT970073E (enExample)
RO (1) RO119719B1 (enExample)
SA (1) SA98190082B1 (enExample)
SI (1) SI0970073T1 (enExample)
SK (1) SK285036B6 (enExample)
TR (1) TR199901936T2 (enExample)
TW (1) TW399050B (enExample)
UA (1) UA54487C2 (enExample)
WO (1) WO1998035963A1 (enExample)
ZA (1) ZA981207B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2097408A4 (en) * 2006-12-27 2010-08-25 Hetero Drugs Ltd IMPROVED PROCESS FOR THE PREPARATION OF EPROSARTAN
EP2295431A3 (en) * 2007-07-25 2011-08-03 Hetero Drugs Limited Substantially pure eprosartan free base
WO2009013760A2 (en) * 2007-07-25 2009-01-29 Hetero Drugs Limited Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan
WO2009084028A2 (en) * 2007-12-03 2009-07-09 Neuland Laboratories Ltd Improved process for manufacturing anhydrous (e)-3-[2-butyl-1- {(4-carboxyphenyl) methyl}-1h-imidazole-5-yl]-(thiophen-2- ylmethyl)prop-2-enoic acid methane sulfonate
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
EP2257540A2 (en) * 2008-03-31 2010-12-08 Hetero Research Foundation Improved process for eprosartan intermediate
WO2010023688A2 (en) * 2008-08-25 2010-03-04 Matrix Laboratories Limited An improved process for the preparation of eprosartan
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
WO2011051975A1 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of pure eprosartanand its pharmaceutical acceptable salts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
MX9605794A (es) * 1994-05-20 1997-12-31 Smithkline Beecham Corp Intermediario para preparar un compuesto farmaceuticamente activo.

Also Published As

Publication number Publication date
UA54487C2 (uk) 2003-03-17
BG63804B1 (bg) 2003-01-31
PL192838B1 (pl) 2006-12-29
HU228781B1 (en) 2013-05-28
ZA981207B (en) 1998-11-12
OA11146A (en) 2003-04-16
CA2281708A1 (en) 1998-08-20
AR011125A1 (es) 2000-08-02
ATE280765T1 (de) 2004-11-15
CZ296349B6 (cs) 2006-02-15
AP1128A (en) 2002-12-06
EA001659B1 (ru) 2001-06-25
NO993913D0 (no) 1999-08-13
TR199901936T2 (xx) 2000-04-21
DE69827240T2 (de) 2005-10-13
PL335075A1 (en) 2000-04-10
PT970073E (pt) 2005-02-28
EG23935A (en) 2008-01-14
AU6150898A (en) 1998-09-08
TW399050B (en) 2000-07-21
AU730383B2 (en) 2001-03-08
EA199900740A1 (ru) 2000-02-28
SK108799A3 (en) 2000-05-16
CY2555B1 (en) 2008-07-02
SK285036B6 (sk) 2006-05-04
BG103650A (en) 2000-06-30
ES2231963T3 (es) 2005-05-16
DE69827240D1 (de) 2004-12-02
EP0970073B1 (en) 2004-10-27
CN1247539A (zh) 2000-03-15
MY118704A (en) 2005-01-31
SA98190082B1 (ar) 2006-08-20
JP2001510466A (ja) 2001-07-31
HUP0001994A3 (en) 2001-07-30
HUP0001994A2 (hu) 2001-06-28
NO993913L (no) 1999-08-13
ID23181A (id) 2000-03-23
IL131309A (en) 2002-09-12
IL131309A0 (en) 2001-01-28
MA24470A1 (fr) 1998-10-01
IN187999B (enExample) 2002-08-03
PE59299A1 (es) 1999-09-09
AP9901620A0 (en) 1999-09-30
KR100573638B1 (ko) 2006-04-26
DK0970073T3 (da) 2005-02-21
CO4950550A1 (es) 2000-09-01
SI0970073T1 (en) 2005-02-28
US6172237B1 (en) 2001-01-09
NO317194B1 (no) 2004-09-13
EP0970073A1 (en) 2000-01-12
CA2281708C (en) 2007-08-14
KR20000071007A (ko) 2000-11-25
JP4537499B2 (ja) 2010-09-01
CN1085208C (zh) 2002-05-22
CZ285299A3 (cs) 2000-02-16
RO119719B1 (ro) 2005-02-28
WO1998035963A1 (en) 1998-08-20
BR9808664A (pt) 2000-07-11
NZ337180A (en) 2000-11-24
EP0970073A4 (en) 2001-01-24

Similar Documents

Publication Publication Date Title
BE2018C032I2 (enExample)
IN188411B (enExample)
IN187999B (enExample)
ITMI971059A0 (enExample)
IN183487B (enExample)
BE2013C047I2 (enExample)
BR9701757A (enExample)
IN191442B (enExample)
ITMI970360V0 (enExample)
IN191400B (enExample)
ITMI971356A0 (enExample)
BR9700653A (enExample)
CN3055519S (enExample)
CN3055389S (enExample)
CN3055713S (enExample)
CN3056358S (enExample)
CN3056419S (enExample)
CN3053248S (enExample)
CN3053524S (enExample)
CN3056367S (enExample)
CN3053002S (enExample)
CN3054753S (enExample)
CN3056209S (enExample)
BY4349C1 (enExample)
CN3054556S (enExample)